Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
Κατάταξη σε μετοχές
#3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Τιμή μετοχής
$4.87
Κεφαλαιοποίηση
$4.36B
Αλλαγή (1 ημέρα)
-5.47%
Αλλαγή (1 έτος)
-15.62%
Χώρα
CN
Εμπόριο Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Κατηγορία
Healthcare
Δείκτης P/S για Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Δείκτης P/S στις October 2026 TTM: 6.59
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, ο τρέχων δείκτης P/S (TTM) είναι 6.59. Στο τέλος του 2024, ο δείκτης ήταν 11.09.
Ιστορικό P/S για την Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd από 2006 έως 2026
Δείκτης P/S στο τέλος κάθε έτους
| Έτος | P/S Ratio | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 6.59 | 9.03% |
| 2025 | 6.04 | -45.55% |
| 2024 | 11.09 | -17.86% |
| 2023 | 13.50 | 42.44% |
| 2022 | 9.48 | -21.14% |
| 2021 | 12.02 | -45.65% |
| 2020 | 22.12 | -9.73% |
| 2019 | 24.50 | 0.76% |
| 2018 | 24.32 | -3.03% |
| 2017 | 25.08 | -11.90% |
| 2016 | 28.47 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | -100.00% |
| 2012 | 46.19 | -21.47% |
| 2011 | 58.81 | -21.40% |
| 2010 | 74.82 | 0.00% |
| 2009 | 0.00 | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | 0.00% |
Δείκτης P/S για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | P/S Ratio | Διαφορά P/S Ratio | Χώρα |
|---|---|---|---|
| 10.72 | 62.80% |
US
|
|
| 41.70 | 533.21% |
US
|
|
| 4.19 | -36.36% |
AU
|
|
| 5.80 | -12.00% |
BE
|
|
| 10.44 | 58.57% |
NL
|
